Monique M Legemaat1, Irene P Jongerden2, Roland M F P T van Rens3, Marjanne Zielman4, Agnes van den Hoogen5. 1. Nursing Science, program in Clinical Health Sciences, Faculty of Medicine, Utrecht University, The Netherlands; Merem Asthma Centre Heideheuvel, Hilversum, The Netherlands. Electronic address: mlegemaat@merem.nl. 2. Nursing Science, program in Clinical Health Sciences, Faculty of Medicine, Utrecht University, The Netherlands; Department of Intensive Care Medicine, University Medical Center Utrecht, The Netherlands. 3. Department of Neonatology Erasmus MC-Sophia's Childrens Hospital, Rotterdam, The Netherlands; Hamad Medical Corporation, Doha, Qatar. 4. Nursing Science, program in Clinical Health Sciences, Faculty of Medicine, Utrecht University, The Netherlands; Reformed University for Applied Sciences, Zwolle, The Netherlands. 5. Nursing Science, program in Clinical Health Sciences, Faculty of Medicine, Utrecht University, The Netherlands; Department of Neonatology, Wilhelmina Children's Hospital, University Medical Center, Utrecht, The Netherlands.
Abstract
OBJECTIVE: To review the effect of a vascular access team on the incidence of central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit. DATA SOURCES: MEDLINE, CINAHL, Embase, Web-of-Science and the Cochrane Library were searched until December 2013. STUDY SELECTION: Studies that evaluated the implementation of a vascular access team, and focused on the incidence of central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit, were selected. DATA EXTRACTION: Incidence rates of central line-associated bloodstream infections were extracted, as well as information on vascular access team tasks and team composition. The quality of studies was critically appraised using the McMaster tool for quantitative studies. DATA SYNTHESIS: Seven studies involving 136 to 414 participants were included. In general, the implementation of a vascular access team coincided with the implementation of concurrent interventions. All vascular access teams included nurses, and occasionally included physicians. Main tasks included insertion and maintenance of central lines. In all studies, a relative decrease of 45-79% in central line-associated bloodstream infections was reported. CONCLUSIONS: A vascular access team is a promising intervention to decrease central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit. However, level of evidence for effectiveness is low. Future research is required to improve the strength of evidence for vascular access teams.
OBJECTIVE: To review the effect of a vascular access team on the incidence of central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit. DATA SOURCES: MEDLINE, CINAHL, Embase, Web-of-Science and the Cochrane Library were searched until December 2013. STUDY SELECTION: Studies that evaluated the implementation of a vascular access team, and focused on the incidence of central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit, were selected. DATA EXTRACTION: Incidence rates of central line-associated bloodstream infections were extracted, as well as information on vascular access team tasks and team composition. The quality of studies was critically appraised using the McMaster tool for quantitative studies. DATA SYNTHESIS: Seven studies involving 136 to 414 participants were included. In general, the implementation of a vascular access team coincided with the implementation of concurrent interventions. All vascular access teams included nurses, and occasionally included physicians. Main tasks included insertion and maintenance of central lines. In all studies, a relative decrease of 45-79% in central line-associated bloodstream infections was reported. CONCLUSIONS: A vascular access team is a promising intervention to decrease central line-associated bloodstream infections in infants admitted to a neonatal intensive care unit. However, level of evidence for effectiveness is low. Future research is required to improve the strength of evidence for vascular access teams.
Authors: Mohammad A A Bayoumi; Roland van Rens; Prem Chandra; Deena Shaltout; Ashraf Gad; Einas E Elmalik; Samer Hammoudeh Journal: BMJ Open Date: 2022-04-06 Impact factor: 2.692
Authors: Tristen T Chun; Dejah R Judelson; David Rigberg; Peter F Lawrence; Robert Cuff; Sherene Shalhub; Max Wohlauer; Christopher J Abularrage; Papapetrou Anastasios; Shipra Arya; Bernadette Aulivola; Melissa Baldwin; Donald Baril; Carlos F Bechara; William E Beckerman; Christian-Alexander Behrendt; Filippo Benedetto; Lisa F Bennett; Kristofer M Charlton-Ouw; Amit Chawla; Matthew C Chia; Sungsin Cho; Andrew M T L Choong; Elizabeth L Chou; Anastasiadou Christiana; Raphael Coscas; Giovanni De Caridi; Sharif Ellozy; Yana Etkin; Peter Faries; Adrian T Fung; Andrew Gonzalez; Claire L Griffin; London Guidry; Nalaka Gunawansa; Gary Gwertzman; Daniel K Han; Caitlin W Hicks; Carlos A Hinojosa; York Hsiang; Nicole Ilonzo; Lalithapriya Jayakumar; Jin Hyun Joh; Adam P Johnson; Loay S Kabbani; Melissa R Keller; Manar Khashram; Issam Koleilat; Bernard Krueger; Akshay Kumar; Cheong Jun Lee; Alice Lee; Mark M Levy; C Taylor Lewis; Benjamin Lind; Gabriel Lopez-Pena; Jahan Mohebali; Robert G Molnar; Nicholas J Morrissey; Raghu L Motaganahalli; Nicolas J Mouawad; Daniel H Newton; Jun Jie Ng; Leigh Ann O'Banion; John Phair; Zoran Rancic; Ajit Rao; Hunter M Ray; Aksim G Rivera; Limael Rodriguez; Clifford M Sales; Garrett Salzman; Mark Sarfati; Ajay Savlania; Andres Schanzer; Mel J Sharafuddin; Malachi Sheahan; Sammy Siada; Jeffrey J Siracuse; Brigitte K Smith; Matthew Smith; Ina Soh; Rebecca Sorber; Varuna Sundaram; Scott Sundick; Tadaki M Tomita; Bradley Trinidad; Shirling Tsai; Ageliki G Vouyouka; Gregory G Westin; Michael S Williams; Sherry M Wren; Jane K Yang; Jeniann Yi; Wei Zhou; Saqib Zia; Karen Woo Journal: J Vasc Surg Date: 2020-07-15 Impact factor: 4.860